Journal of Alzheimer s Disease,
Journal Year:
2022,
Volume and Issue:
94(s1), P. S399 - S428
Published: Sept. 6, 2022
Parkinson's
disease
(PD)
is
the
second
most
common
neurodegenerative
illness
majorly
affecting
population
between
ages
of
55
to
65
years.
Progressive
dopaminergic
neuronal
loss
and
collective
assemblage
misfolded
alpha-synuclein
in
substantia
nigra,
remain
notable
neuro-pathological
hallmarks
disease.
Multitudes
mechanistic
pathways
have
been
proposed
attempts
unravel
pathogenesis
PD
but
still,
it
remains
elusive.
The
convergence
pathology
found
organelle
dysfunction
where
mitochondria
a
major
contributor.
Mitochondrial
processes
like
bioenergetics,
mitochondrial
dynamics,
mitophagy
are
under
strict
regulation
by
genome
nuclear
genome.
These
aggravate
activities
upon
alteration
through
neuroinflammation,
oxidative
damage,
apoptosis,
proteostatic
stress.
Therefore,
grabbed
central
position
patho-mechanistic
exploration
diseases
PD.
management
challenge
physicians
date,
due
variable
therapeutic
response
patients
limitation
conventional
chemical
agents
which
only
offer
symptomatic
relief
with
minimal
no
disease-modifying
effect.
This
review
describes
involved
not
limited
protein
dyshomeostasis
stress,
explicit
attention
has
drawn
exploring
mechanisms
dysfunction,
primarily
influence,
while
delineating
newer
exploratory
targets
such
as
GBA1,
GLP,
LRRK2,
miRNAs
targeting
them.
Signal Transduction and Targeted Therapy,
Journal Year:
2024,
Volume and Issue:
9(1)
Published: May 15, 2024
Abstract
Mitochondria,
with
their
intricate
networks
of
functions
and
information
processing,
are
pivotal
in
both
health
regulation
disease
progression.
Particularly,
mitochondrial
dysfunctions
identified
many
common
pathologies,
including
cardiovascular
diseases,
neurodegeneration,
metabolic
syndrome,
cancer.
However,
the
multifaceted
nature
elusive
phenotypic
threshold
dysfunction
complicate
our
understanding
contributions
to
diseases.
Nonetheless,
these
complexities
do
not
prevent
mitochondria
from
being
among
most
important
therapeutic
targets.
In
recent
years,
strategies
targeting
have
continuously
emerged
transitioned
clinical
trials.
Advanced
intervention
such
as
using
healthy
replenish
or
replace
damaged
mitochondria,
has
shown
promise
preclinical
trials
various
Mitochondrial
components,
mtDNA,
mitochondria-located
microRNA,
associated
proteins
can
be
potential
agents
augment
function
immunometabolic
diseases
tissue
injuries.
Here,
we
review
current
knowledge
pathophysiology
concrete
examples
We
also
summarize
treat
perspective
dietary
supplements
targeted
therapies,
well
translational
situation
related
pharmacology
agents.
Finally,
this
discusses
innovations
applications
transplantation
an
advanced
promising
treatment.
Biomedicine & Pharmacotherapy,
Journal Year:
2023,
Volume and Issue:
167, P. 115652 - 115652
Published: Oct. 4, 2023
Mitochondria
maintain
the
normal
physiological
function
of
nerve
cells
by
producing
sufficient
cellular
energy
and
performing
crucial
roles
in
maintaining
metabolic
balance
through
intracellular
Ca2+
homeostasis,
oxidative
stress,
axonal
development.
Depression
is
a
prevalent
psychiatric
disorder
with
an
unclear
pathophysiology.
Damage
to
hippocampal
neurons
key
component
plasticity
regulation
synapses
plays
critical
role
mechanism
depression.
There
evidence
suggesting
that
mitochondrial
dysfunction
associated
synaptic
impairment.
The
maintenance
homeostasis
includes
quantitative
quality
control
mitochondria.
Mitochondrial
biogenesis
produces
new
healthy
mitochondria,
dynamics
cooperates
mitophagy
remove
damaged
These
processes
population
stability
exert
neuroprotective
effects
against
early
In
contrast,
observed
various
brain
regions
patients
major
depressive
disorders.
accumulation
defective
mitochondria
accelerates
dysfunction.
addition,
impaired
aggravate
alterations
microenvironment,
promoting
neuroinflammation
depletion,
thereby
exacerbating
development
This
review
summarizes
influence
underlying
molecular
pathways
on
pathogenesis
Additionally,
we
discuss
as
potential
therapeutic
strategy
for
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(17), P. 13033 - 13033
Published: Aug. 22, 2023
Neurodegenerative
diseases
(NDs)
are
a
diverse
group
of
disorders
characterized
by
the
progressive
degeneration
and
death
neurons,
leading
to
range
neurological
symptoms.
Despite
heterogeneity
these
conditions,
common
denominator
is
implication
mitochondrial
dysfunction
in
their
pathogenesis.
Mitochondria
play
crucial
role
creating
biomolecules,
providing
energy
through
adenosine
triphosphate
(ATP)
generated
oxidative
phosphorylation
(OXPHOS),
producing
reactive
oxygen
species
(ROS).
When
they’re
not
functioning
correctly,
becoming
fragmented
losing
membrane
potential,
they
contribute
diseases.
In
this
review,
we
explore
how
mitochondria
fuse
undergo
fission,
especially
context
NDs.
We
discuss
genetic
protein
mutations
linked
impact
dynamics.
also
look
at
key
regulatory
proteins
fusion
(MFN1,
MFN2,
OPA1)
fission
(DRP1
FIS1),
including
post-translational
modifications.
Furthermore,
highlight
potential
drugs
that
can
influence
By
unpacking
complex
processes,
aim
direct
research
towards
treatments
improve
life
quality
for
people
with
challenging
conditions.
Advanced Materials,
Journal Year:
2024,
Volume and Issue:
36(18)
Published: Jan. 15, 2024
Abstract
Mitochondria,
widely
known
as
the
energy
factories
of
eukaryotic
cells,
have
a
myriad
vital
functions
across
diverse
cellular
processes.
Dysfunctions
within
mitochondria
serve
catalysts
for
various
diseases,
prompting
widespread
demise.
Mounting
research
on
remedying
damaged
indicates
that
constitute
valuable
target
therapeutic
intervention
against
diseases.
But
less
clinical
practice
and
lower
recovery
rate
imply
limitation
traditional
drugs,
which
need
further
breakthrough.
Nanotechnology
has
approached
favorable
regiospecific
biodistribution
high
efficacy
by
capitalizing
excellent
nanomaterials
targeting
drug
delivery.
Mitochondria‐remedying
nanodrugs
achieved
ideal
effects.
This
review
elucidates
significance
in
cells
organs,
while
also
compiling
mortality
data
related
Correspondingly,
nanodrug‐mediate
strategies
applicable
mitochondria‐remedying
disease
are
detailed,
with
full
understanding
roles
dysfunction
advantages
nanodrugs.
In
addition,
future
challenges
directions
discussed.
conclusion,
this
provides
comprehensive
insights
into
design
development
nanodrugs,
aiming
to
help
scientists
who
desire
extend
their
fields
engage
interdisciplinary
subject.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: March 15, 2024
Mounting
evidence
progressively
appreciates
the
vital
interplay
between
immunity
and
metabolism
in
a
wide
array
of
immunometabolic
chronic
disorders,
both
autoimmune
non-autoimmune
mediated.
The
immune
system
regulates
functioning
cellular
within
organs
like
brain,
pancreas
and/or
adipose
tissue
by
sensing
adapting
to
fluctuations
microenvironment’s
nutrients,
thereby
reshaping
metabolic
pathways
that
greatly
impact
pro-
or
anti-inflammatory
immunophenotype.
While
it
is
agreed
relies
on
an
adequate
nutritional
status
function
properly,
we
are
only
just
starting
understand
how
supply
single
combined
all
them
termed
immunonutrients,
can
steer
cells
towards
less
inflamed,
tolerogenic
Polyphenols,
class
secondary
metabolites
abundant
Mediterranean
foods,
pharmacologically
active
natural
products
with
outstanding
immunomodulatory
actions.
Upon
binding
range
receptors
highly
expressed
(e.g.
AhR,
RAR,
RLR),
they
act
through
mitochondria-centered
multi-modal
approach.
First
,
polyphenols
activate
nutrient
via
stress-response
pathways,
essential
for
responses.
Second
regulate
mammalian
target
rapamycin
(mTOR)/AMP-activated
protein
kinase
(AMPK)
balance
well-tolerated
caloric
restriction
mimetics.
Third
interfere
assembly
NLR
family
pyrin
domain
containing
3
(NLRP3)
endoplasmic
reticulum-mitochondria
contact
sites,
inhibiting
its
activation
while
improving
mitochondrial
biogenesis
autophagosome-lysosome
fusion.
Finally
chromatin
remodeling
coordinates
epigenetic
reprogramming.
This
work
moves
beyond
well-documented
antioxidant
properties
polyphenols,
offering
new
insights
into
multifaceted
nature
these
compounds.
It
proposes
mechanistical
appraisal
regulatory
which
modulate
response,
alleviating
low-grade
inflammation.
Furthermore,
draws
parallels
pharmacological
interventions
polyphenol-based
immunonutrition
their
modes
immunomodulation
across
spectrum
socioeconomically
impactful
diseases
such
as
Multiple
Sclerosis,
Diabetes
(type
1
2)
even
Alzheimer’s
disease.
Lastly,
discusses
existing
challenges
thwart
translation
polyphenols-based
immunonutritional
long-term
clinical
studies.
Overcoming
limitations
will
undoubtedly
pave
way
precision
nutrition
protocols
provide
personalized
guidance
tailored
plans.
Progress in Retinal and Eye Research,
Journal Year:
2022,
Volume and Issue:
95, P. 101136 - 101136
Published: Nov. 16, 2022
Glaucoma
is
a
leading
cause
of
irreversible
blindness
worldwide
and
characterized
by
slow,
progressive,
multifactorial
degeneration
retinal
ganglion
cells
(RGCs)
their
axons,
resulting
in
vision
loss.
Despite
its
high
prevalence
individuals
60
years
age
older,
the
causing
factors
contributing
to
glaucoma
progression
are
currently
not
well
characterized.
Intraocular
pressure
(IOP)
only
proven
treatable
risk
factor.
However,
lowering
IOP
insufficient
for
preventing
disease
progression.
One
significant
interests
pathogenesis
understanding
structural
functional
impairment
mitochondria
RGCs
axons
synapses.
Glaucomatous
such
as
elevation,
aging,
genetic
variation,
neuroinflammation,
neurotrophic
factor
deprivation,
vascular
dysregulation,
potential
inducers
mitochondrial
dysfunction
glaucoma.
Because
oxidative
phosphorylation
stress-mediated
associated
with
glaucomatous
RGCs,
underlying
mechanisms
relationship
between
alterations
would
be
beneficial
developing
mitochondria-related
neuroprotection
synapses
against
neurodegeneration.
Here,
we
review
current
studies
focusing
on
dynamics-based
therapeutic
strategies
protect
Cells,
Journal Year:
2022,
Volume and Issue:
11(13), P. 2049 - 2049
Published: June 28, 2022
Amyotrophic
lateral
sclerosis
(ALS)
is
a
rapidly
progressive
and
highly
fatal
neurodegenerative
disease.
Although
the
pathogenesis
of
ALS
remains
unclear,
increasing
evidence
suggests
that
key
contributing
factor
mitochondrial
dysfunction.
Mitochondria
are
organelles
in
eukaryotic
cells
responsible
for
bioenergy
production,
cellular
metabolism,
signal
transduction,
calcium
homeostasis,
immune
responses
stability
their
function
plays
crucial
role
neurons.
A
single
disorder
or
defect
can
lead
to
pathological
changes
cells,
such
as
an
impaired
buffer
period,
excessive
generation
free
radicals,
increased
membrane
permeability,
oxidative
stress
(OS).
Recent
research
has
also
shown
these
dysfunctions
associated
with
believed
be
commonly
involved
This
article
reviews
latest
on
dysfunction
its
impact
progression
ALS,
specific
attention
potential
novel
therapeutic
strategies
targeting
Vaccines,
Journal Year:
2023,
Volume and Issue:
11(2), P. 408 - 408
Published: Feb. 10, 2023
The
coronavirus
2019
(COVID-19)
pandemic
was
caused
by
a
positive
sense
single-stranded
RNA
(ssRNA)
severe
acute
respiratory
syndrome
2
(SARS-CoV-2).
However,
other
human
coronaviruses
(hCoVs)
exist.
Historical
pandemics
include
smallpox
and
influenza,
with
efficacious
therapeutics
utilized
to
reduce
overall
disease
burden
through
effectively
targeting
competent
host
immune
system
response.
is
composed
of
primary/secondary
lymphoid
structures
initially
eight
types
cell
types,
many
subtypes,
traversing
membranes
utilizing
signaling
cascades
that
contribute
towards
clearance
pathogenic
proteins.
Other
proteins
discussed
cluster
differentiation
(CD)
markers,
major
histocompatibility
complexes
(MHC),
pleiotropic
interleukins
(IL),
chemokines
(CXC).
historical
concepts
immunity
are
the
innate
adaptive
systems.
represented
T
cells,
B
antibodies.
macrophages,
neutrophils,
dendritic
complement
system.
viruses
can
affect
regulate
cycle
progression
for
example,
in
cancers
papillomavirus
(HPV:
cervical
carcinoma),
Epstein-Barr
virus
(EBV:
lymphoma),
Hepatitis
C
(HB/HC:
hepatocellular
carcinoma)
Leukemia
Virus-1
(T
leukemia).
Bacterial
infections
also
increase
risk
developing
cancer
(e.g.,